Found vs CoreAgeRx: Pricing, Personalization Compared
Found vs CoreAgeRx: this comparison quickly shows Found emphasizes a biology-first, personalized medically supervised program with plans starting as low as $39, while CoreAgeRx emphasizes flat, unchanging monthly pricing such as $79/month for semaglutide and $129/month for tirzepatide. Early verdict: choose Found for a personalized, insurance-friendly approach; choose CoreAgeRx if you want predictable flat monthly pricing.
Start Found: See plans starting as low as $39
Found vs CoreAgeRx: 3 to 5 key differences
This side by side comparison focuses on five distinctive differences supported by the sources: pricing and billing model, personalization and program focus, insurance and paperwork handling, medication types and compounded status, and clinician review with dosing details.
1. Pricing model and starting price
Found offers “get started for as low as $39” and describes affordable monthly plans with flexible pricing and membership tiers. CoreAgeRx positions itself on flat monthly pricing and emphasizes “Same Price. Every Month.” CoreAgeRx lists $79/month for semaglutide up to 1.0 mg and $129/month for tirzepatide up to 7.5 mg.
Explore CoreAgeRx pricing: lock in flat monthly cost
2. Personalization and program emphasis
Found frames its service as a biology-first, personalized medically supervised weight loss program that builds plans around individual metabolic biology including hormones, blood sugar, sleep and behavior. CoreAgeRx centers messaging on consistent pricing and short online visits and does not supply captured evidence of a biology-first personalization approach.
Learn Found’s biology-first approach
3. Insurance, paperwork and membership
Found states “Most insurance now accepted” and says it handles insurance paperwork. Found advertises options such as brand-name access via Medicare GLP-1 Bridge Program and notes pricing and coverage vary by insurance and commitments. CoreAgeRx states “No insurance required” and highlights “No memberships” and no billing surprises, with captured evidence noting consumers should confirm eligibility and terms before enrollment.
4. Medication types, compounded status and regulatory notes
Both sources mention GLP-1 medications. Found lists tirzepatide, semaglutide and compounded options and explicitly states “Compounded GLP-1s are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” CoreAgeRx lists tirzepatide and semaglutide dosing caps and includes the note that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
5. Clinician review, eligibility and dose details
Found says prescriptions are subject to provider review and clinical eligibility. CoreAgeRx states treatment is available only when a licensed clinician determines it is medically appropriate and includes dosing claims: any dose up to 7.5 mg for tirzepatide and up to 1.0 mg for semaglutide as captured on the landing page.
Comparison table: Found vs CoreAgeRx
| Criteria | Found | CoreAgeRx |
|---|---|---|
| Starting price | Get started for as low as $39 | $79/mo semaglutide; $129/mo tirzepatide |
| Billing model | Affordable monthly plans; flexible pricing; membership options | Flat monthly pricing; no membership; “Same Price. Every Month.” |
| Personalization | Biology-first personalized medically supervised program | 3-minute online visit emphasis; personalization not captured |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | No insurance required; confirm eligibility and terms |
| Medications | Tirzepatide, semaglutide, compounded options; regulatory note on compounding | Tirzepatide up to 7.5 mg; semaglutide up to 1.0 mg; confirm approval status |
| Clinician review | Rx subject to provider review and clinical eligibility | Treatment only when a licensed clinician determines it is medically appropriate |
How the choices differ in practical terms
If predictable flat monthly billing is your highest priority and you prefer not to use insurance, CoreAgeRx advertises consistent prices like $79/mo for semaglutide and $129/mo for tirzepatide and emphasizes no membership fees or price increases. If you want a program that emphasizes metabolic biology, hormone and lifestyle factors and may work with your insurance, Found documents a biology-first personalized approach and says it handles insurance paperwork with plans starting as low as $39.
Compare Found plans and insurance options
Conclusion: Found vs CoreAgeRx
Found vs CoreAgeRx comes down to personalization and insurance versus flat predictable pricing. Found emphasizes a biology-first, medically supervised program, flexible pricing and insurance paperwork handling with plans starting as low as $39 and notes compounded GLP-1s are not FDA-approved. CoreAgeRx emphasizes same monthly price every month, lists $79/month for semaglutide and $129/month for tirzepatide, and stresses no memberships and price stability but advises confirming eligibility and terms.
Choose Found if you want a biology-first personalized program that handles insurance paperwork and offers plans starting as low as $39. Choose CoreAgeRx if you want flat predictable monthly pricing such as $79/mo semaglutide or $129/mo tirzepatide and prefer no membership model.